These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 19201061

  • 1. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
    Chalmers JD, Singanayagam A, Scally C, Hill AT.
    Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
    [Abstract] [Full Text] [Related]

  • 2. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.
    Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ.
    Am J Med; 2005 Apr; 118(4):384-92. PubMed ID: 15808136
    [Abstract] [Full Text] [Related]

  • 3. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.
    Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, Na SH, Hwang SS.
    J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD, Singanayagam A, Hill AT.
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [Abstract] [Full Text] [Related]

  • 6. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B.
    Crit Care; 2006 Mar; 10(3):R96. PubMed ID: 16805922
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
    Thiem U, Niklaus D, Sehlhoff B, Stückle C, Heppner HJ, Endres HG, Pientka L.
    Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia.
    Cerda-Mancillas MC, Santiago-Germán D, Andrade-Bravo B, Pedraza-Olivares F, Valenzo-Hernández F, Leaños-Miranda A, Isordia-Salas I.
    Arch Med Res; 2020 Jul; 51(5):429-435. PubMed ID: 32402575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prospective comparison of prediction rules of mortality risk for CAP in a developing country.
    Zuberi FF, Khan JA.
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):447-52. PubMed ID: 18371273
    [Abstract] [Full Text] [Related]

  • 17. Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis.
    Bloom BJ, Alario AJ, Miller LC.
    J Rheumatol; 2009 Feb; 36(2):422-6. PubMed ID: 19040298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.
    Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML.
    Clin Infect Dis; 2008 Aug 01; 47(3):375-84. PubMed ID: 18558884
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.